Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesAdministrative/Operational PolicyBlue Cross Blue Shield - Texas Prior Auth Update |…
    Ask Trek AI about this page
    CurrentBlue Cross Blue Shield - TexasPolicy N/A

    Prior Authorization Services for Other Administrative Services Only (ASO) Members

    Customize your policy alerts

    Sign up for all Blue Cross Blue Shield - Texas policy alerts

    Know when Blue Cross Blue Shield - Texas releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    This policy describes prior authorization processes and services that require prior authorization for Blue Cross Blue Shield of Texas ASO members and guides providers on verification and clinical review processes.

    Policy Summary
    PayerBlue Cross Blue Shield - Texas
    PolicyPrior Authorization Services for Other Administrative Services Only (ASO) Members
    Policy CodePolicy N/A
    Change TypeTechnical update (no material clinical changes)
    Effective DateJan 1, 2025
    Last ReviewOct 1, 2024
    Next Review DateN/A
    Key ActionCheck eligibility and benefits via Availity Essentials and seek clinical review within 48 hours for unplanned inpatient admissions.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    48+service types listed
    48 hrs

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    clinical review timeframe
    Carelon, Magellan, Alacuravendor partners
    MCG, BCBSTX, ASAM, TDIcriteria sources named

    Clinical and Screening Criteria

    Clinical screening and operational criteria sources

    Clinical and operational screening criteria referenced and how they are applied when evaluating prior authorization requests for ASO members.

    ALL of the following

    • MCG Care Guidelines

      Used for medical/surgical and mental health screening

    • BCBSTX Medical Policies

      Primary source for medical necessity determinations and provider‑administered drug therapy reviews; medical policies reference authoritative sources such as MCG, DrugDex, NCCN and FDA‑approved labeling

    • American Society of Addiction Medicine (ASAM) Criteria

      Applied for SUD and certain behavioral health determinations (also referenced by Magellan where applicable)

    • Texas Department of Insurance standards for reasonable cost control and utilization review for SUD treatment centers

      Applied for SUD services provided in Texas

    • Carelon Evidence‑based Guidelines (vendor)

      Vendor‑specific evidence‑based guidance used for categories managed by Carelon

    • Magellan Healthcare Guidelines (vendor)

      Vendor guidelines and ASAM criteria used for plans managed by Magellan

    • Pharmacy authoritative sources for Provider Administered Drug Therapy Reviews (package inserts, DrugDex, NCCN, etc.)

      Medical policies plus these sources are used to determine appropriate dose, frequency, and duration for drug therapies

    ALL of the following

    • Providers must verify benefit design and prior authorization requirements through Availity Essentials or the appropriate vendor portal

      Not all criteria or vendor requirements apply to every product; verify plan design

    • Vendor responsibility: Carelon and Magellan may manage prior authorization and apply their evidence‑based guidelines for specific outpatient categories or plan lines

      Refer to vendor routing in the policy for advanced imaging, molecular testing, musculoskeletal/radiation therapy and other vendor‑managed categories

    ALL of the following

    • MCG, BCBSTX medical policies, ASAM, TDI, Carelon and Magellan guidelines are applied as screening and clinical criteria when reviewing requests
    • For drug therapies covered under medical benefits, medical policies are supplemented by package inserts, DrugDex, NCCN and similar authoritative references

    ALL of the following

    • Providers should confirm whether a specific service or code requires prior authorization for the member's plan; downloadable code lists may be available where indicated

    Codes and Pharmacy Prior Authorization

    Code lists referenced but not includedmixed
    Document notes that specific codes are not available and refers readers to downloadable lists of outpatient procedure and mental health procedure codes that require prior authorization for Other ASO members.
    Pharmacy prior authorization requirement
    Where to checkSome medications require prior authorization under pharmacy benefits; providers should check the Drug List Guide and the PA/Step Therapy Program information linked in the plan materials.
    ScopePharmacy prior authorization applies to certain drugs covered under the pharmacy benefit; applicability may vary by ASO account and plan design.
    Related resourcesClick here to review clinical criteria applied for drugs covered by Pharmacy Benefits (policy references DrugDex, NCCN, package inserts).
    Operational noteVerify benefit design and prior authorization requirements via Availity or plan-specific communications, as not all requirements apply to every product.

    Provider Verification, Authorization, and Admission Actions

    Prior Authorization

    Verification and Clinical Review Timeframe

    Providers must verify member eligibility and benefits and check prior authorization requirements via Availity Essentials before delivering services. For all unplanned inpatient admissions (surgical, non‑surgical, mental health, or substance use), request a clinical review within 48 hours of admission to reduce the risk of post‑service medical necessity denials.

    • Check eligibility/benefits and prior authorization requirements through Availity Essentials.
    • Seek clinical review within 48 hours for all unplanned inpatient admissions.
    Prior Authorization

    Services Requiring Prior Authorization (non‑exhaustive)

    The following services (non‑exhaustive) require prior authorization for Other Administrative Services Only (ASO) members. Confirm specific plan design and code lists before rendering services.

    • Durable Medical Equipment (varies by plan design)
    • Home health services including home private duty nursing (PDN) and home infusion therapy (HIT)

    Key Definitions

    Provider Administered Drug Therapy Reviews
    DefinitionProvider Administered Drug Therapy Reviews are medical necessity reviews that leverage BCBSTX medical policies plus authoritative references such as package inserts, DrugDex, and NCCN.
    Evidence baseReviews rely on medical policies which are based on current peer-reviewed scientific literature, FDA‑approved labeling, and nationally recognized authoritative references (e.g., MCG, DrugDex, NCCN, professional society guidelines, CMS coverage).
    Review focusFor drug therapy, the proposed dose, frequency, and duration must be consistent with recommendations in at least one authoritative source to be considered appropriate.
    PurposeTo determine medical necessity and ensure requested therapies are proven effective for the relevant diagnosis or procedure according to referenced guidelines and labeling.
    Medical policies
    Policy Summary
    PayerBlue Cross Blue Shield - Texas
    PolicyPrior Authorization Services for Other Administrative Services Only (ASO) Members
    Policy CodePolicy N/A
    Change TypeTechnical update (no material clinical changes)
    Effective DateJan 1, 2025
    Last ReviewOct 1, 2024
    Next Review DateN/A
    Key ActionCheck eligibility and benefits via Availity Essentials and seek clinical review within 48 hours for unplanned inpatient admissions.
    SourceLink
    On This Page
    Clinical and Screening CriteriaCodes and Pharmacy Prior AuthorizationProvider Verification, Authorization, and Admission ActionsKey Definitions
  1. Home hemodialysis
  2. Home hospice
  3. Home infusion therapy (HIT)
  4. Medical transportation (managed through Alacura Medical Transportation Management)
  5. Non‑emergency fixed‑wing air ambulance
  6. Transplant evaluations and transplants
  7. Out‑of‑network/out‑of‑plan services
  8. Outpatient elective surgery received in an out‑of‑network hospital or ambulatory surgical center
  9. Dialysis obtained from an out‑of‑network provider
  10. Chiropractic services (may be reviewed against benefit limits)
  11. Occupational/Physical/Speech Therapy (may be reviewed against benefit limits)
  12. Inpatient admissions (acute, LTAC, skilled nursing facility, rehabilitation) and behavioral health/SUD residential or inpatient admissions
  13. Specialty pharmacy medications and provider‑administered drug therapies requiring medical necessity review
  14. Select outpatient behavioral health services (e.g., ECT, ABA, IOP, PHP, psychological/neuropsych testing, rTMS)
  15. Prior Authorization

    Vendor‑Specific Outpatient Prior Authorization Responsibilities

    Certain outpatient categories are managed by delegated vendors (Carelon Medical Benefits Management) or by BCBSTX directly. Providers must submit prior authorization requests to the indicated vendor/program for the listed outpatient services.

    • Carelon-managed outpatient prior authorization categories: Advanced imaging (radiology, cardiology), Molecular genetic laboratory testing, Musculoskeletal services (joint, spine surgery, musculoskeletal pain), Radiation therapy / radiation oncology, Oncology medications and supportive care medical reviews.
    • BCBSTX-managed or other indicated programs: Select outpatient services such as sleep services (Carelon noted for sleep), cardiology lipid apheresis, gastroenterology, ENT, neurology, outpatient surgery (e.g., breast procedures, headache trigger deactivation, jaw), pain management, and wound care — confirm the appropriate manager (Carelon vs BCBSTX) for each service.
    • Specialty pharmacy and provider‑administered drugs: Infusion site‑of‑care reviews and medical necessity reviews for therapies are required; many oncology drug reviews are routed through Carelon.
    Prior Authorization

    Specialty Pharmacy and Provider‑Administered Drug Review Actions

    Specialty pharmacy medications covered under medical benefits and provider‑administered therapies require medical necessity review. Infusion site‑of‑care determinations are required for applicable therapies and place‑of‑infusion reviews may be performed. Oncology drugs and supportive care that are consistent with an oncology diagnosis require review (managed through Carelon where indicated).

    • Infusion site‑of‑care medical necessity review required for applicable therapies and infusion locations.
    • Medical oncology and supportive care drug reviews managed through Carelon when supported by an oncology diagnosis.
    • Provider‑administered drug therapies require medical necessity review; confirm routing for review (Carelon or BCBSTX).
    Prior Authorization

    Inpatient and Behavioral Health Prior Authorization Expectations

    Admission notification and authorization expectations apply to acute care hospitals (including hospice, maternity, medical, surgical, transplant), long‑term acute care/sub‑acute, skilled nursing facilities, and rehabilitation facilities. Behavioral health and substance use disorder inpatient and residential admissions also require notification and, where applicable, prior authorization and clinical review.

    • Notify payer and seek clinical review/authorization for acute inpatient hospital admissions (medical, surgical, maternity, transplant, hospice) as indicated by the ASO account.
    • Notify and obtain authorization for long‑term acute care, sub‑acute, skilled nursing facility, and rehabilitation admissions when required by the plan.
    • Behavioral health and SUD inpatient and residential treatment center admissions require notification and applicable prior authorization/clinical review.
    • For certain ASO accounts, inpatient services are a recommended clinical review — confirm account‑specific requirements.
    Definition
    Medical policies are written guidelines that support current standards of practice and are based on current peer‑reviewed scientific literature.
    Role in reviewThey are used to determine whether a requested therapy is proven effective for the relevant diagnosis or procedure and to guide appropriate dosing, frequency, and duration.
    Supporting referencesMedical policies are supported by FDA‑approved labeling and nationally recognized authoritative references (e.g., MCG, DrugDex, NCCN, professional society guidelines, CMS coverage).
    ApplicationMedical policies inform clinical screening criteria applied during prior authorization and Provider Administered Drug Therapy Reviews.